Open AccessA nuclear protein associated with human cancer cells binds preferentially to a human repetitive DNA sequence.
Author(s) -
Martha Liao Law,
Jizong Gao,
Theodore T. Puck
Publication year - 1989
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.86.21.8472
Subject(s) - microbiology and biotechnology , dna , nuclear protein , biology , cell culture , human genome , chinese hamster ovary cell , repeated sequence , dna binding protein , biochemistry , genetics , gene , genome , transcription factor
A protein (Rp66) of 66 kDa was shown by DNA-binding protein blot assay to bind to a human repetitive DNA sequence (low-repeat sequence; LRS) in each of 10 transformed human cell lines examined. This protein-DNA interaction was not observed in 11 normal human cell cultures or in the Chinese hamster cell line CHO-K1. Gel retardation assay confirmed the specificity of the protein-DNA binding between Rp66 and LRS. In a histiocytic lymphoma human cell line, U937, that can be induced to differentiate in the presence of phorbol ester, this binding disappeared after cell differentiation. These together with other results cited suggest a regulatory role for these repetitive sequences in the human genome, with particular application to cancer.